ロード中...
Quality of evidence considered by Health Canada in granting full market authorisation to new drugs with a conditional approval: a retrospective cohort study
OBJECTIVES: This study examines the characteristics of studies that Health Canada uses to grant full marketing authorisation for products given a conditional approval between 1 January 1998 and 30 June 2017. DESIGN: Cohort study. DATA SOURCES: Journal articles listing drugs that fulfilled their cond...
保存先:
| 出版年: | BMJ Open |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5931291/ https://ncbi.nlm.nih.gov/pubmed/29705760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-020377 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|